John Trant, PhD

Department of Chemistry and Biochemistry, University of Windsor Dendronized enzymatically-resistant carbohydrate vaccines for treating lung cancer Therapeutic vaccines incorporating sugar molecules could provide new cancer treatments. Because over 85% of carcinoma cancer cells, regardless of organ, display the same few sugars on their surface, sugars not found on healthy cells, these sugars are promising targets…


Jeffrey Chen, PhD

VIDO-InterVac, University of Saskatchewan Towards a next generation of superior BCG tuberculosis vaccines Tuberculosis is a serious global health problem, with one-third of the world’s population having been infected by the infectious agent, Mycobacterium tuberculosis. The only available tuberculosis vaccine, live M. bovis BCG vaccine, has an excellent record in protecting infants, but works poorly…


Dave Richard, PhD

Département de microbiologie-infectiologie et d’immunologie, Université Laval Protein trafficking to the apical complex of the malaria parasite Malaria is one of the world’s most common infectious diseases, with approximately 274 million cases each year and 1 million deaths, and thus represents one of the most devastating global public health problems.